Celgene is a pharmaceutical company committed to the development of innovative drugs designed to prolong and improve the lives of people with life-threatening, chronic and/or debilitating haemato-oncological and immuno-inflammatory diseases.
The 2018 Celgene Scholarship, which will provide funding in the amount of €10,000 for new projects, with a scope extending also to chronic and debilitating neurological or rheumatic diseases.
Applicants to the 2018 Celgene Scholarship should submit their projects from May 15 to June 15, 2018.